🚨SURVIVOR-WATCH — Late Effects + Recurrence Signals to Recognize
Most fears in prostate cancer survivorship — biochemical recurrence (rising PSA), bone metastasis, cardiovascular event (especially on ADT), severe ADT side effects, mental health crash — are addressable when caught early. The patterns below are the high-leverage signals that warrant a same-day or urgent call. Severe symptoms = 911. Partners often notice mood and energy changes before the survivor names them.
🎯Three Phases · One Force Field
Every square belongs to one of three phases of mastery. Inside each square's detail panel, the four sections — Concepts · Skills · Actions · Plan — are the building blocks of these phases. (Note: ASCO also describes three survivorship phases — acute, extended, permanent — that map onto the years after diagnosis. Don't confuse the two; they reinforce each other.)
📘 Learn It Tier 1 · Aware
Identity earned: Self-Advocate. The "know" — what survivorship is (acute vs extended vs permanent), the long-term and late effects you should expect, your treatment summary (Gleason at diagnosis, PSA nadir, current PSA, treatment received — surgery / RT / active surveillance / ADT / oral hormonal agents), surveillance schedule, and the ASCO Survivorship Care Plan.
🛠 Live It Tier 2 · Active
Identity earned: Care-Team Member. The "do" — PSA cadence, urinary continence work, sexual-health work, ADT side-effect management (hot flashes, bone loss, metabolic syndrome, mood, sexual), the modifiable lifestyle stack (weight, exercise, Mediterranean diet, alcohol, sleep), DXA + lipid + A1c monitoring, mental-health screening with PHQ-9 / GAD-7.
📣 Share It Tier 3 · Certified
Identity earned: Ambassador. The "carry forward" — sexual / continence / relationship conversations; talking to sons (BRCA testing, family-history-aware screening discussions); mentor a newly-finished-treatment survivor via ZERO / Us TOO / PCF; advocate for equitable access (AA mortality is 2× — addressable).
🛡️Your Force Field — 16 Squares
Click any square to open its detail panel. Each square is a tile in your shield. Keep clicking, learning, and acting — your Force Field gets stronger every step.
What Survivorship Is
The IOM defines survivorship as the period from diagnosis through the rest of life. ASCO splits it into three phases: acute (active treatment), extended (the first few years after), permanent (long-term, often years to decades). This sheet is for the post-treatment chapters — when active therapy ends and the long arc of surveillance, late effects, and recurrence prevention begins. Includes active-surveillance survivors (a distinct arc).
Primer360 Human Anatomy
Prostate, Pelvis & Treatment Effects
The prostate sits below the bladder, surrounding the urethra; nerves controlling erection run alongside. Surgery (radical prostatectomy) typically affects continence + erectile function. Radiation (external beam, brachytherapy) affects bowel + erectile + urinary, often delayed. ADT (LHRH agonists / antagonists / surgical) affects bone, metabolism, mood, sexual function, cognition. Knowing the anatomy makes the late-effect map make sense.
AnatomyWho Lives This — The Survivor Population
~3.5 million U.S. prostate cancer survivors today. ~290,000 new diagnoses per year; ~35,000 deaths. Most diagnoses are localized (low- to intermediate-risk). ~12% lifetime risk for U.S. men. Disparities are stark: AA men have ~2× mortality and 1.7× incidence; earlier age of diagnosis; higher Gleason at presentation. ~5–10% are hereditary (BRCA1/2, HOXB13, ATM). ~30% choose active surveillance for low-risk disease — a distinct survivorship arc.
PrimerThe Numbers — Survival & Recurrence
5-year overall survival ~97% (localized ~99%). Distant disease ~37%. Long-term survivors often die of cardiovascular disease > prostate cancer itself — modifiable lifestyle and ADT-related metabolic surveillance matter enormously. PSA is the surveillance backbone. Modifiable factors (BMI, exercise — especially resistance training for ADT-related muscle and bone loss, Mediterranean diet, alcohol, smoking cessation) collectively reduce mortality.
PrimerRecognize Late Effects + Recurrence Signals
Late effects to know: erectile dysfunction (very common after surgery and after RT), urinary incontinence (post-prostatectomy primarily), bowel symptoms (post-RT), ADT side effects (hot flashes, bone loss, metabolic syndrome, mood, fatigue, muscle / cognitive). Recurrence signals: rising PSA, new persistent axial bone pain (concerning for metastasis), neurologic symptoms (cord compression risk), urinary retention or hematuria. Same-day call; severe = ED.
Learn ItPSA Surveillance + Survivorship Schedule
PSA monitoring is the surveillance backbone. Cadence varies by treatment: post-prostatectomy q3–6mo for first 1–2 years, then q6–12mo. Post-RT q3–6mo, watching for nadir + 2 (Phoenix definition of biochemical recurrence). ADT: PSA + testosterone. DRE periodically. Bone scan / PSMA PET only on rising PSA or symptoms. DXA baseline + every 1–2 years on ADT. Lipid panel + A1c annually on ADT. Echo / cardio-oncology if extended ADT or pre-existing cardiovascular disease. PHQ-9 / GAD-7 at oncology visits.
Learn ItKnow My Numbers + Treatment Summary
The survivor's lifetime data set: stage at diagnosis, Gleason score / Grade Group, PSA at diagnosis, PSA nadir, current PSA + cadence, treatment received (active surveillance + biopsy history; surgery type + nerve-sparing status; RT field + dose Gy; ADT drug + duration; oral hormonal agents like abiraterone / enzalutamide / apalutamide / darolutamide), testosterone (if on ADT), BRCA / multi-gene panel result (if tested), DXA + lipids + A1c. Bring this to every visit.
Learn ItLifestyle Force Field
Real survival-extension evidence: weight management toward BMI <25 (associated with lower prostate-cancer-specific and overall mortality). Exercise: aerobic AND resistance training — resistance is especially protective against ADT-related muscle and bone loss (ACSM Roundtable). Mediterranean / DASH-style diet (WCRF/AICR; Mediterranean associated with lower prostate-cancer-specific mortality). Alcohol moderation. Smoking cessation (heavy smoking associated with prostate-cancer-specific mortality). Sleep 7–9 hr. Vitamin D adequacy.
Learn ItADT & Other Therapies — Plain Language
ADT (androgen deprivation therapy): LHRH agonists (leuprolide), LHRH antagonists (degarelix, relugolix), surgical (orchiectomy). Dramatic side effects: hot flashes, bone loss, metabolic syndrome, weight gain, mood, fatigue, muscle loss, cognitive, sexual. Bone health protocol: DXA + Ca + vitamin D + bisphosphonate (zoledronic acid) or denosumab if osteoporosis. Metabolic monitoring: lipids + A1c + BP. Oral hormonal agents for advanced disease: abiraterone, enzalutamide, apalutamide, darolutamide. Active surveillance for low-risk: serial PSA + biopsies; not "no treatment" — it's structured monitoring with treatment if disease progresses.
Live ItCare Team Members
Urology / urologic oncology (anchor for surgery + active surveillance) · medical oncology (advanced disease) · radiation oncology (if RT given) · PCP (transition over time, BP, lipids, mental health) · cardio-oncology if extended ADT or pre-existing CV disease · sexual medicine specialist (ED management is a subspecialty) · pelvic-floor / urinary continence PT · behavioral health (depression / anxiety prevalence elevated, especially on ADT) · genetic counseling (if BRCA / hereditary indication) · ZERO Prostate Cancer / Us TOO / PCF peer support.
Live ItTelemedicine & Tech
PSA tracking app or simple log · symptom journal (urinary continence, sexual function, hot flash count, mood, exercise) · MyChart for labs, PSA results, refills · video visits for survivorship clinic, behavioral health, sexual-medicine, genetic counseling · medication reminder apps for oral hormonal agents · PHQ-9 + GAD-7 on phone monthly · BP cuff + scale at home (especially on ADT) · ASCO Survivorship Care Plan template online · pelvic-floor PT apps + Kegel-tracking apps.
TechInsurance, Cost & Help
PSA monitoring is inexpensive and covered. ADT injectables are pricier; copay programs and Medicare Part B cover most. Oral hormonal agents (abiraterone, enzalutamide, apalutamide, darolutamide) under Part D — copay programs help. Survivorship-clinic visits typically covered. ZERO Prostate Cancer Patient Assistance, CancerCare Co-Pay Assistance, Patient Advocate Foundation, NeedyMeds. FMLA for treatment recovery; ADA for accommodations long-term; SSDI for advanced disease.
Live ItEquity, Access & the Disparity Story
The disparities are stark and addressable. African American men: ~2× prostate-cancer-specific mortality, 1.7× incidence; earlier age at diagnosis; higher Gleason at presentation; access to oncology / radiation / clinical trials lags; lower access to genetic counseling. Hispanic men: rising mortality, later-stage at diagnosis. AAPI men: different patterns; rising in some communities. Rural men: distance to specialty care, urology / RT / cardio-oncology gaps. Hereditary patterns: BRCA1/2, HOXB13 — ~5–10%. Honest framing: cause matters less here than access does.
Share ItTalk to Partner, Sons, Employer
Partner: intimacy, sexual function, urinary continence — name them explicitly; sexual-medicine specialist + pelvic-floor PT + couples therapy help. The partner's role in adherence + ADT side-effect education + mental-health watch matters. Sons: family history matters — sons of survivors have ~2x risk; conversation about age-appropriate prostate cancer screening discussions (typically starting age 40–50 with shared decision-making, earlier and more aggressively for AA men or family-history). Hereditary-risk family conversation (BRCA, HOXB13, others) is a powerful Ambassador move. Employer: ADA covers cognitive accommodations, schedule flex, urinary-continence accommodations.
Share ItMentor & Share Insights
ZERO Prostate Cancer, Us TOO International, Prostate Cancer Foundation (PCF), AUA, Malecare all run peer-mentor programs. The newly-finished-treatment survivor who hears "I'm 5 years out from prostatectomy, I'm continent, I have a sexual-health plan, here's what I wish I'd known" gets a different orientation than one who only hears "you're done." Honest framing about the long arc > pep talk. Identity-aligned mentorship matters (AA, Hispanic, age, hereditary status).
Share ItJoin the ROI Study (PHIT)
PHIT — Population Health Impact Tracking. Aggregate & anonymous. Help prove this program improves outcomes — better PSA-surveillance adherence, earlier sexual-medicine + pelvic-floor PT referral, better cardiotoxicity / metabolic surveillance with ADT, more PHQ-9 / GAD-7 screening uptake, more equitable access for AA / Hispanic / rural survivors — for the prostate cancer survivor population.
Study🩺 Hand-off to my Survivorship Team
Print and bring to your next visit. This page tells your team what you have prepared for, what you want to focus on, and how you would like to participate as an active member of your own care team.
- I am a Prepared Patient in training for prostate cancer survivorship. I have reviewed all 16 squares of this Force Field Fact Sheet.
- I have started building my Health Passport, my treatment summary (Gleason, stage, PSA nadir, current PSA, treatment received, ADT plan if applicable), my continence + sexual-function journal, my PHQ-9 + GAD-7 trend, and my ADT side-effect log if applicable to bring to every visit.
- I want to teach back what I have learned and have you correct anything I have misunderstood — especially around my recurrence-risk picture, my PSA cadence, my DXA / lipid / A1c cadence (if on ADT), bone-protection protocol, sexual-medicine + pelvic-floor PT options, BRCA / hereditary status, and when to call vs ED.
What helps my visit
Two minutes for me to teach back. One question I prepared. My Survivorship Care Plan. My med list. Confirm latest PSA, testosterone (if on ADT), DXA, lipids, A1c, PHQ-9 / GAD-7, surveillance schedule on the chart.
What I am working on
PSA cadence on track · weight management toward BMI <25 · aerobic + resistance exercise (especially ADT-protective) · Mediterranean-style diet · alcohol moderation · DXA-driven bone health (if on ADT) · cardio-oncology check-ins if extended ADT · monthly PHQ-9 / GAD-7 · sexual-medicine + pelvic-floor PT plan · BRCA family conversation if applicable.
How I want to participate
Shared decisions. Be honest about late effects and recurrence risk. Tell me your top 1–2 priorities so we agree. Use AHRQ SHARE Approach. Refer to sexual-medicine + pelvic-floor PT early. Cardio-oncology if extended ADT. Behavioral health early, not as last resort. Genetic counseling if any hereditary signal.
🔬 Help Prove This Works — Join the FFH ROI & PHIT Study
The Prepared Patient program is being studied to see whether better preparation actually improves outcomes — better PSA-surveillance adherence, earlier sexual-medicine + pelvic-floor PT referral, better cardiotoxicity / metabolic surveillance with ADT, more PHQ-9 / GAD-7 screening, earlier behavioral-health linkage, more equitable access for AA / Hispanic / rural survivors, complete BRCA / hereditary-risk testing where indicated — for prostate cancer survivors. Your participation is voluntary, your data is aggregated and anonymized, and you can withdraw at any time.
➕ Add-On Force Field Card · Device or Skill Mastery
If your survivorship plan adds a device, treatment, or new skill, bolt on a 5-step Add-On Card. Common bolt-ons for prostate cancer survivors: PSA tracking routine, pelvic-floor / Kegel routine for continence, sexual-medicine plan (PDE5 inhibitors, vacuum erection device, penile injection, implant decision), ADT bone-health protocol (DXA / Ca / vit D / bisphosphonate or denosumab), cardio-oncology echo cadence (if extended ADT), PHQ-9 / GAD-7 monthly self-check, BRCA / genetic counseling visit, Survivorship Care Plan request, active-surveillance biopsy schedule.
Introduce
What it is, why it matters, what it does
Coach
Watch a demo + walk-through
Practice
Do it with a coach watching
Train
Use it daily with a check-in
Test
Demonstrate competence + earn badge
Ready to go deeper?
The Prepared Patient · Prostate Cancer Survivor course turns this fact sheet into a guided journey: pre/post knowledge checks, ASCO three-phase survivorship framing, treatment-summary literacy, ADT and other therapies, the modifiable lifestyle stack, sexual-medicine + pelvic-floor PT, bone-health protocol, cardio-oncology with ADT, PHQ-9 / GAD-7 mental-health rhythm, the Survivorship Care Plan, the BRCA / hereditary conversation, and your printable Health Passport. Earn Aware → Active → Certified.